291 related articles for article (PubMed ID: 22828206)
21. Protective immunity of E. coli-synthesized NS1 protein of Japanese encephalitis virus.
Lin CW; Liu KT; Huang HD; Chen WJ
Biotechnol Lett; 2008 Feb; 30(2):205-14. PubMed ID: 17876533
[TBL] [Abstract][Full Text] [Related]
22. Immunogenicity of baculovirus expressed recombinant proteins of Japanese encephalitis virus in mice.
Yang DK; Kweon CH; Kim BH; Lim SI; Kwon JH; Kim SH; Song JY; Han HR
J Vet Sci; 2005 Jun; 6(2):125-33. PubMed ID: 15933432
[TBL] [Abstract][Full Text] [Related]
23. An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses.
Lobigs M; Pavy M; Hall RA; Lobigs P; Cooper P; Komiya T; Toriniwa H; Petrovsky N
J Gen Virol; 2010 Jun; 91(Pt 6):1407-17. PubMed ID: 20130134
[TBL] [Abstract][Full Text] [Related]
24. Sublingual immunization with Japanese encephalitis virus vaccine effectively induces immunity through both cellular and humoral immune responses in mice.
Lee EY; Kim JY; Lee DK; Yoon IS; Ko HL; Chung JW; Chang J; Nam JH
Microbiol Immunol; 2016 Dec; 60(12):846-853. PubMed ID: 28004418
[TBL] [Abstract][Full Text] [Related]
25. The immunogenicity of tetravalent dengue DNA vaccine in mice pre-exposed to Japanese encephalitis or Dengue virus antigens.
Prompetchara E; Ketloy C; Keelapang P; Sittisombut N; Ruxrungtham K
Asian Pac J Allergy Immunol; 2015 Sep; 33(3):182-8. PubMed ID: 26342114
[TBL] [Abstract][Full Text] [Related]
26. Enhancing the utility of a prM/E-expressing chimeric vaccine for Japanese encephalitis by addition of the JEV NS1 gene.
Ishikawa T; Wang G; Widman DG; Infante E; Winkelmann ER; Bourne N; Mason PW
Vaccine; 2011 Oct; 29(43):7444-55. PubMed ID: 21798299
[TBL] [Abstract][Full Text] [Related]
27. Poly-γ-glutamic acid nanoparticles and aluminum adjuvant used as an adjuvant with a single dose of Japanese encephalitis virus-like particles provide effective protection from Japanese encephalitis virus.
Okamoto S; Yoshii H; Matsuura M; Kojima A; Ishikawa T; Akagi T; Akashi M; Takahashi M; Yamanishi K; Mori Y
Clin Vaccine Immunol; 2012 Jan; 19(1):17-22. PubMed ID: 22089248
[TBL] [Abstract][Full Text] [Related]
28. Low Protective Efficacy of the Current Japanese Encephalitis Vaccine against the Emerging Genotype 5 Japanese Encephalitis Virus.
Cao L; Fu S; Gao X; Li M; Cui S; Li X; Cao Y; Lei W; Lu Z; He Y; Wang H; Yan J; Gao GF; Liang G
PLoS Negl Trop Dis; 2016 May; 10(5):e0004686. PubMed ID: 27139722
[TBL] [Abstract][Full Text] [Related]
29. Bacterially expressed recombinant envelope protein domain III of Japanese encephalitis virus (rJEV-DIII) elicits Th1 type of immune response in BALB/c mice.
Verma SK; Kumar S; Gupta N; Vedi S; Bhattacharya SM; Lakshmana Rao PV
Vaccine; 2009 Nov; 27(49):6905-9. PubMed ID: 19761840
[TBL] [Abstract][Full Text] [Related]
30. Electroporation enhances protective immune response of a DNA vaccine against Japanese encephalitis in mice and pigs.
Sheng Z; Gao N; Cui X; Fan D; Chen H; Wu N; Wei J; An J
Vaccine; 2016 Nov; 34(47):5751-5757. PubMed ID: 27743649
[TBL] [Abstract][Full Text] [Related]
31. Virus-specific cytolytic antibodies to nonstructural protein 1 of Japanese encephalitis virus effect reduction of virus output from infected cells.
Krishna VD; Rangappa M; Satchidanandam V
J Virol; 2009 May; 83(10):4766-77. PubMed ID: 19264772
[TBL] [Abstract][Full Text] [Related]
32. A specific and sensitive antigen capture assay for NS1 protein quantitation in Japanese encephalitis virus infection.
Li YZ; Counor D; Lu P; Liang GD; Vu TQ; Phan TN; Huynh TK; Sun G; Grandadam M; Butrapet S; Lavergne JP; Flamand M; Yu YX; Solomon T; Buchy P; Deubel V
J Virol Methods; 2012 Jan; 179(1):8-16. PubMed ID: 21704081
[TBL] [Abstract][Full Text] [Related]
33. Immunization with pseudotype baculovirus expressing envelope protein of Japanese encephalitis virus elicits protective immunity in mice.
Li Y; Ye J; Cao S; Xiao S; Zhao Q; Liu X; Jin M; Chen H
J Gene Med; 2009 Feb; 11(2):150-9. PubMed ID: 19040206
[TBL] [Abstract][Full Text] [Related]
34. Fragment of Japanese encephalitis virus envelope protein produced in Escherichia coli protects mice from virus challenge.
Chia SC; Leung PS; Liao CP; Huang JH; Lee ST
Microb Pathog; 2001 Jul; 31(1):9-19. PubMed ID: 11427032
[TBL] [Abstract][Full Text] [Related]
35. Double-subgenomic Sindbis virus recombinants expressing immunogenic proteins of Japanese encephalitis virus induce significant protection in mice against lethal JEV infection.
Pugachev KV; Mason PW; Shope RE; Frey TK
Virology; 1995 Oct; 212(2):587-94. PubMed ID: 7571428
[TBL] [Abstract][Full Text] [Related]
36. Targeting the non-structural protein 1 from dengue virus to a dendritic cell population confers protective immunity to lethal virus challenge.
Henriques HR; Rampazo EV; Gonçalves AJ; Vicentin EC; Amorim JH; Panatieri RH; Amorim KN; Yamamoto MM; Ferreira LC; Alves AM; Boscardin SB
PLoS Negl Trop Dis; 2013; 7(7):e2330. PubMed ID: 23875054
[TBL] [Abstract][Full Text] [Related]
37. Co-expression of Japanese encephalitis virus prM-E-NS1 antigen with granulocyte-macrophage colony-stimulating factor enhances humoral and anti-virus immunity after DNA vaccination.
Gao N; Chen W; Zheng Q; Fan DY; Zhang JL; Chen H; Gao GF; Zhou DS; An J
Immunol Lett; 2010 Mar; 129(1):23-31. PubMed ID: 20064558
[TBL] [Abstract][Full Text] [Related]
38. A Chimeric Japanese Encephalitis Vaccine Protects against Lethal Yellow Fever Virus Infection without Inducing Neutralizing Antibodies.
Mishra N; Boudewijns R; Schmid MA; Marques RE; Sharma S; Neyts J; Dallmeier K
mBio; 2020 Apr; 11(2):. PubMed ID: 32265332
[TBL] [Abstract][Full Text] [Related]
39. Replicon-based Japanese encephalitis virus vaccines elicit immune response in mice.
Huang Y; Liu S; Yang P; Wang C; Du Y; Yu W; Sun Z
J Virol Methods; 2012 Jan; 179(1):217-25. PubMed ID: 22108431
[TBL] [Abstract][Full Text] [Related]
40. Complete protection for mice conferred by a DNA vaccine based on the Japanese encephalitis virus P3 strain used to prepare the inactivated vaccine in China.
Zheng X; Yu X; Wang Y; Turtle L; Cui M; Wang R; Yin C
Virol J; 2020 Aug; 17(1):126. PubMed ID: 32831096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
